II
ELV icon

Impact Investors’s Elevance Health ELV Stock Holding History

Impact Investors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-798
Closed -$234K – 97
2026
Q1 		$234K Sell
798
-696
-47% -$229K 0.16% 86
2025
Q4 		$524K Sell
1,494
-168
-10% -$56.8K 0.36% 52
2025
Q3 		$537K Buy
1,662
+22
+1% +$6.84K 0.35% 57
2025
Q2 		$638K Buy
1,640
+63
+4% +$25.3K 0.45% 49
2025
Q1 		$686K Buy
1,577
+37
+2% +$14.9K 0.53% 42
2024
Q4 		$568K Buy
+1,540
New +$644K 0.44% 46

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Impact Investors's ELV Position: Q2 2026 in Review

Impact Investors sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 798 shares — an estimated $234K sold.

Impact Investors first reported a position in ELV in Q4 2024 and held it in 6 quarters. The position peaked at $686K in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Impact Investors reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Impact Investors sold 798 Elevance Health shares in Q2 2026, an estimated $234K.
  • Impact Investors first reported a position in Elevance Health in Q4 2024 and held it in 6 quarters.
  • Impact Investors's Elevance Health position peaked at $686K in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Impact Investors's 13F filing for Q2 2026, filed 31 Jul 2026.